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Alzheimer’s disease: Clues from flies and worms
Brian H. Anderton
Presenilin mutations give rise to familial Alzheimer’s
disease and result in elevated production of amyloid b
peptide. Recent evidence that presenilins act in
developmental signalling pathways may be the key to
understanding how senile plaques, neurofibrillary
tangles and apoptosis are all biochemically linked.
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The classical pathological hallmarks of Alzheimer’s
disease are senile neuritic plaques and neurofibrillary
tangles in the brain. Senile plaques consist of an extracel-
lular core of deposited amyloid β peptide surrounded by
degenerating neuronal processes. Neurofibrillary tangles
are intraneuronal aggregates of paired helical filaments,
which are assembled from hyperphosphorylated forms of
the microtubule-associated protein tau. The dementia
characteristic of Alzheimer’s disease is the consequence of
selective neuronal loss. Neurofibrillary tangles cause the
death of neurons that contain them, but another cause of
cell death may be direct toxicity of amyloid β peptide.
There is evidence that at least some of the neuronal cell
death in Alzheimer’s disease is via apoptosis, but precisely
how amyloid β peptide deposition, neurofibrillary tangle
formation and the mechanism of cell death are linked has
so far eluded researchers. But now clues to possible
biochemical links between these processes are beginning
to emerge as a result of recent genetic discoveries.
Most cases of autosomal dominant Alzheimer’s disease are
caused by mutations in the presenilin-1 gene on
chromosome 14, a variety of which (more than 50) have
been described so far. In a few pedigrees, the disease is
associated with mutations in the homologous gene
presenilin-2 on chromosome 1. Presenilin 1 and presenilin 2
are transmembrane proteins, probably with eight
transmembrane domains, that are located primarily in the
endoplasmic reticulum and Golgi apparatus. Several
observations have indicated that presenilins play a part in
signalling by Notch, which is known to have a number of
important roles in development. Thus, both presenilins
are homologous to Sel-12, a protein required for Notch
signalling in the nematode Caenorhabditis elegans, possibly
because they have a role in the processing and/or intracel-
lular transport of Notch before it arrives at the plasma
membrane [1]. And presenilin-1 knockout mice die in utero
with a phenotype similar to Notch mutants. 
In addition to possibly having a developmental role in
Notch signalling, presenilins in the brain have been shown
to influence proteolytic processing of the amyloid precur-
sor protein. Amyloid precursor protein is a single-pass
transmembrane protein that is subject to several alterna-
tive proteolytic cleavages, including ones that release two
forms of amyloid β peptide: one of 40 amino acids (Aβ40)
and the other of 42 amino acids (Aβ42). The longer form
Aβ42 has a greater tendency to aggregate into fibrils, which
have been shown to be neurotoxic, acting by induction of
neuronal apoptosis. The expression in transgenic mice of a
form of presenilin 1 carrying a mutation associated with
autosomal dominant Alzheimer’s disease was found to
result in an increase in the Aβ42:Aβ40 ratio. As it seems
that Aβ42 is produced in the endoplasmic reticulum, and
Aβ40 in the Golgi apparatus, presenilins may influence
amyloid β peptide production via an effect on the intra-
cellular transport of amyloid precursor protein (Figure 1).
Most researchers in the field have argued, on the basis of
these observations, that mutations in the presenilin genes
predispose individuals to Alzheimer’s disease by promot-
ing amyloid β peptide deposition in the brain, resulting in
neuronal loss.
Several groups have recently shown that presenilins
associate directly with β-catenin [2–6]. This is intriguing,
because β-catenin is a component of the intracellular
signal transduction pathway that mediates responses to
the cell–cell signalling molecule Wingless/Wnt —
Drosophila/vertebrate forms of the ligand, respectively —
and there is genetic evidence in Drosophila that the Notch
and Wingless pathways interact at the level of a protein
called Dishevelled, or Dvl in vertebrates (Figure 1).
Activation of the Wnt pathway by binding of extracellular
Wnt-1 to its receptor, Frizzled, results in inhibition of
glycogen synthase kinase-3β (GSK-3β) by an unknown
mechanism involving Dvl and probably protein kinase C,
which inactivates GSK-3β through phosphorylation [7].
GSK-3β phosphorylates ‘adenomatous polyposis coli’
protein (APC) and β-catenin, which both occur within cells
in a complex with GSK-3β. Phosphorylated β-catenin is
then ubiquitinated and degraded via the proteasome
pathway. So when GSK-3β is inhibited as a result of activa-
tion of the Wnt pathway, the cytoplasmic levels of β-catenin
rise, a response commonly referred to as ‘β-catenin stabili-
sation’. This increase in its cytoplasmic level is accompa-
nied by the translocation of some β-catenin to the nucleus,
where it regulates gene expression through interaction
with members of the Tcf/LEF family of transcription
factors [7]. Although tau is a substrate for several protein
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kinases, GSK-3β is the best candidate for being the
enzyme that generates the hyperphosphorylated tau that
is characteristic of paired helical filaments [8]. So are the
Notch and Wnt signalling pathways the keys to
understanding Alzheimer’s disease? Several recent papers
suggest that they might be, but unfortunately not entirely
in a consistent manner.
Zhang et al. [2] found that, in several cell types, presenilin
1 occurs in a complex with β-catenin, APC and GSK-3β.
They also showed, by immunofluorescence microscopy,
that β-catenin and presenilin 1 are co-localised in the
Golgi apparatus. Some β-catenin was also localised at the
plasma membrane — presumably complexed to cadherins
— and some presenilin 1 was present in the endoplasmic
reticulum. The obvious question to address was whether
mutant presenilins could influence β-catenin metabolism
and, especially, ‘stabilisation’. 
In their paper, Zhang et al. [2] imply that overexpression
of wild-type presenilin 1 does result in stabilisation of 
β-catenin, and that mutant presenilin 1 does this less
effectively. But they did not actually measure stabilisation
— the levels of cytoplasmic β-catenin — but rather the
turnover of total cellular β-catenin, both cytoplasmic and
membrane-bound forms. They found that overexpression
of wild-type presenilin 1 in transfected cells resulted in a
slower turnover rate for β-catenin, as measured by
pulse–chase labelling, and that the β-catenin turnover rate
in cells making mutant presenilin 1 was higher than that in
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A hypothetical scheme by which Notch and Wingless/Wnt signalling
might link the processing of amyloid precursor protein (APP) — to
APPS, Aβ40 and Aβ42 — and tau hyperphosphorylation. GSK-3β
phosphorylates tau, and when the Notch/Wnt pathway is stimulated,
GSK-3β is inhibited and β-catenin is ‘stabilised’ in the cytoplasm. As
the cytoplasmic levels of β-catenin rise, some is translocated to the
nucleus, where it interacts with transcription factors (LEF/Tcf).
Presenilins regulate the production of amyloid β-peptide, some of
which occurs in the endoplasmic reticulum (ER). Although it is unclear
if presenilins physically interact with amyloid precursor protein or
Notch, presenilins do appear to regulate processing and intracellular
transport of amyloid precursor protein and Notch — potentially closing
a regulatory loop that involves both amyloid precursor protein and tau.
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cells making wild-type presenilin 1. Consistent with this,
they found lowers levels of β-catenin in extracts of brain
samples from Alzheimer’s cases with presenilin 1 muta-
tions compared to controls or sporadic Alzheimer’s cases.
And in fibroblasts from presenilin 1 mutant mouse embryos
they observed increased levels of β-catenin degradation
products, indicating that presenilin 1 is required to main-
tain a basal physiological level of β-catenin.
In a further set of experiments, Zhang et al. [2] investi-
gated whether β-catenin plays a role in apoptosis induced
by amyloid β peptide. They found that primary rat
hippocampal neurons were more vulnerable to apoptosis
induction by amyloid β peptide when they were
transfected with a construct encoding a dominant-negative
mutant form of β-catenin. Co-transfection with a construct
encoding wild-type β-catenin reversed the effect. A
dominant-negative version of the Tcf transcription factor
also rendered the neurons more vulnerable to apoptosis,
both in the absence and presence of amyloid β peptide,
and again this was reversed when the cells also made 
wild-type Tcf. 
These observations may provide a mechanism explaining
earlier findings in which expression of mutant presenilin 1
rendered cells more vulnerable to amyloid β peptide
toxicity [9]. They also imply that possession of a mutant pre-
senilin gene could be a ‘doubly whammy’ by both increasing
Aβ42 production and making neurons more vulnerable to
amyloid β peptide toxicity. But as Zhang et al. [2] acknowl-
edged, the complete opposite effect of β-catenin and Tcf on
apoptosis has been reported [10]. In this latter study, it was
found that reduced levels of β-catenin and expression of a
dominant-negative mutant Tcf rescued cells from apoptosis.
Zhang et al. [2] suggest the contrasting results may reflect
the fact that different types of cells respond in different
ways, but this seems a weak argument for such a ubiqui-
tously expressed signalling pathway.
The paper from Zhang et al. [2] is certainly interesting and
important, but it does not address the mechanism by
which presenilins regulate β-catenin metabolism. The
slowed β-catenin turnover as a result of presenilin over-
expression, which is less in the case of mutant presenilins,
might simply occur because there is a larger pool of a
membrane-bound binding partner — presenilin 1 — for 
β-catenin, isolating it from the proteasome pathway. In
presenilin 1 mutant cells, the lack of such a binding partner
could result in increased degradation, and Alzheimer’s
brain samples with one wild-type and one mutant presenilin
1 allele may have reduced presenilin 1-binding capacity for
β-catenin. A recent paper by Murayama et al. [3], however,
does take us one step further towards a mechanism.
Murayama et al. [3] transiently over-expressed wild-type
and mutant forms of presenilin 1 in COS-7 cells and
assayed cytoplasmic β-catenin levels — thus they assayed
true β-catenin stabilisation. They found that both wild-
type and mutant forms of presenilin 1 reduced β-catenin
stabilisation but did not affect the level of membrane-
bound β-catenin. They also measured Tcf activation using
a reporter construct and found that it was reduced by over-
expression of wild-type presenilin 1, but even more
reduced in the presence of mutant presenilin 1. These
effects on β-catenin and Tcf seem partly to be in contra-
diction to the findings reported by Zhang et al. [2].
Takashima et al. [4] have also reported that GSK-3β is in
the complex of presenilin 1 and β-catenin, but they addi-
tionally found that tau was present in this complex. They
found that two mutant forms of presenilin 1 bound more
GSK-3β than did wild-type presenilin 1 and that, in cells
expressing these two mutant presenilins, co-transfected
tau was phosphorylated, whereas in cells expressing wild-
type presenilin 1, the co-transfected tau was not phos-
phorylated. These findings potentially link presenilins,
already known to affect amyloid β peptide production,
with tau hyperphosphorylation.
What to make of these reports? Well firstly, there now
seems little doubt that β-catenin is present in complexes
with presenilins in cells, and that GSK-3β is probably also
in the same complexes. There is really no dispute over
finding that mutant presenilins cause an increase in Aβ42
production. An important outstanding issue as far as
Alzheimer’s disease pathogenesis is concerned is whether
mutant presenilins increase GSK-3β activity, perhaps via
Notch and forming a closed regulatory loop (Figure 1),
which then results in tau hyperphosphorylation and 
β-catenin destabilisation. Alternatively, some other mech-
anism may link presenilins to β-catenin metabolism, such
as differential binding to wild-type and mutant presenilins
and hence sequestration from the cytoplasmic pool. The
mechanism is likely to be resolved in the near future, as
already many researchers interested in Notch and wing-
less/Wnt signalling are excited about the possibility of
unravelling what’s going on in Alzheimer’s disease.
Perhaps we may then understand how both senile plaques
and neurofibrillary tangles are produced in concert.
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If you found this dispatch interesting, you might also want
to read the February 1999 issue of
Current Opinion in
Neurobiology
which included the following reviews, edited
by David J Anderson and Lynn T
Landmesser, on Development:
Control of neurogenesis — lessons from frogs, fish 
and flies
Ajay B Chitnis
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Mary Hynes and Arnon Rosenthal
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Constance L Cepko
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Christo Goridis and Jean-François Brunet
Control of muscle fibre and motoneuron diversification
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David M Lin and John Ngai
Formation of lamina-specific synaptic connections
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networks of the vertebrate nervous system
Michael J O’Donovan
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Patterned electrical activity and gene regulation in
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The full text of Current Opinion in Neurobiology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/nrb
